Healthcare -
Biotechnology - NASDAQ - US
$ 1.82
-1.09 %
$ 382 M
Market Cap
-1.17
P/E
ALLO - CASH FROM OPERATIONS
Cash from Operations ALLO - Allogene Therapeutics, Inc.
-238 M
LAST VALUE
-13.42%
2 YEAR CAGR
-39.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR